Genetic and environmental risk factors for idiopathic inflammatory myopathies

Ann M. Reed, Steven R Ytterberg

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Although the studies discussed are beginning to reveal a number of genetic and possible environmental risk factors for myositis, further investigations are needed to fully understand and classify these syndromes. The difficulties in this process include small numbers of subjects with varying disease phenotypes available for study, polygenic risk factors for which it remains unclear which are primary and which are secondary or linked genes, and the lack of validated environmental exposure assessment tools. New technologies and international collaborative approaches, however, may overcome some of these difficulties and allow us to identify genetic and environmental risk factors, as well as the critical gene-environment interactions in the IIM and its subgroups. Nonetheless, our understanding of these diseases is still in the early stages. Although we have learned a great deal about these disorders through detailed investigations over the last several decades, we have even further to go to understand the environmental triggers and genetic susceptibilities for the myositis syndromes.

Original languageEnglish (US)
Pages (from-to)891-916
Number of pages26
JournalRheumatic Disease Clinics of North America
Volume28
Issue number4
DOIs
StatePublished - Nov 2002

Fingerprint

Myositis
Gene-Environment Interaction
Environmental Exposure
Genetic Predisposition to Disease
Technology
Phenotype
Genes

ASJC Scopus subject areas

  • Rheumatology

Cite this

Genetic and environmental risk factors for idiopathic inflammatory myopathies. / Reed, Ann M.; Ytterberg, Steven R.

In: Rheumatic Disease Clinics of North America, Vol. 28, No. 4, 11.2002, p. 891-916.

Research output: Contribution to journalArticle

@article{5b8bafbec8864d77a2e9ba14b35528cf,
title = "Genetic and environmental risk factors for idiopathic inflammatory myopathies",
abstract = "Although the studies discussed are beginning to reveal a number of genetic and possible environmental risk factors for myositis, further investigations are needed to fully understand and classify these syndromes. The difficulties in this process include small numbers of subjects with varying disease phenotypes available for study, polygenic risk factors for which it remains unclear which are primary and which are secondary or linked genes, and the lack of validated environmental exposure assessment tools. New technologies and international collaborative approaches, however, may overcome some of these difficulties and allow us to identify genetic and environmental risk factors, as well as the critical gene-environment interactions in the IIM and its subgroups. Nonetheless, our understanding of these diseases is still in the early stages. Although we have learned a great deal about these disorders through detailed investigations over the last several decades, we have even further to go to understand the environmental triggers and genetic susceptibilities for the myositis syndromes.",
author = "Reed, {Ann M.} and Ytterberg, {Steven R}",
year = "2002",
month = "11",
doi = "10.1016/S0889-857X(02)00029-7",
language = "English (US)",
volume = "28",
pages = "891--916",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Genetic and environmental risk factors for idiopathic inflammatory myopathies

AU - Reed, Ann M.

AU - Ytterberg, Steven R

PY - 2002/11

Y1 - 2002/11

N2 - Although the studies discussed are beginning to reveal a number of genetic and possible environmental risk factors for myositis, further investigations are needed to fully understand and classify these syndromes. The difficulties in this process include small numbers of subjects with varying disease phenotypes available for study, polygenic risk factors for which it remains unclear which are primary and which are secondary or linked genes, and the lack of validated environmental exposure assessment tools. New technologies and international collaborative approaches, however, may overcome some of these difficulties and allow us to identify genetic and environmental risk factors, as well as the critical gene-environment interactions in the IIM and its subgroups. Nonetheless, our understanding of these diseases is still in the early stages. Although we have learned a great deal about these disorders through detailed investigations over the last several decades, we have even further to go to understand the environmental triggers and genetic susceptibilities for the myositis syndromes.

AB - Although the studies discussed are beginning to reveal a number of genetic and possible environmental risk factors for myositis, further investigations are needed to fully understand and classify these syndromes. The difficulties in this process include small numbers of subjects with varying disease phenotypes available for study, polygenic risk factors for which it remains unclear which are primary and which are secondary or linked genes, and the lack of validated environmental exposure assessment tools. New technologies and international collaborative approaches, however, may overcome some of these difficulties and allow us to identify genetic and environmental risk factors, as well as the critical gene-environment interactions in the IIM and its subgroups. Nonetheless, our understanding of these diseases is still in the early stages. Although we have learned a great deal about these disorders through detailed investigations over the last several decades, we have even further to go to understand the environmental triggers and genetic susceptibilities for the myositis syndromes.

UR - http://www.scopus.com/inward/record.url?scp=0036866041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036866041&partnerID=8YFLogxK

U2 - 10.1016/S0889-857X(02)00029-7

DO - 10.1016/S0889-857X(02)00029-7

M3 - Article

VL - 28

SP - 891

EP - 916

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 4

ER -